ANIX
Anixa Biosciences (ANIX)
$
01About Anixa Biosciences (ANIX)
Anixa Biosciences, Inc. is a biotechnology company, which engages in the development of therapies and vaccines focused on oncology and infectious disease. It operates through the following segments: CAR-T Therapeutics, Cancer Vaccines, Anti-Viral Therapeutics, and Other. The CAR-T Therapeutics segment involves the development of immuno-therapy drugs against cancer. The Cancer Vaccines segment includes the early stages development of immunization for breast and ovarian cancer. The company was founded on November 5, 1982 and is headquartered San Jose, CA.
Details
Daily high
$3.06
Daily low
$2.97
Price at open
$3.00
52 Week High
$5.13
52 Week Low
$2.14
Market cap
96.9M
Dividend yield
0.00%
Volume
40,083
Avg. volume
48,512
P/E ratio
-7.71
Anixa Biosciences News
Details
Daily high
$3.06
Daily low
$2.97
Price at open
$3.00
52 Week High
$5.13
52 Week Low
$2.14
Market cap
96.9M
Dividend yield
0.00%
Volume
40,083
Avg. volume
48,512
P/E ratio
-7.71